{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-041748","form_type":"8-K","ticker":null,"cik":"0001600847","company_name":"Gamida Cell Ltd.","filed_at":"2023-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.608208+00:00","generated_at":"2026-06-14T18:16:08.214661+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Gamida Cell appoints Terry Coelho as CFO; Shai Lankry to depart June 2","bullets":["Terry Coelho appointed CFO effective May 22, 2023; she has over 35 years of finance experience at biopharma companies.","Shai Lankry steps down as CFO and will leave the company on June 2, 2023; transition was planned since August 2022.","Coelho compensated at $500/hr for first 25 hrs/week and $400/hr thereafter; recommended for 10,000 share options vesting by May 22, 2024 or upon a merger/sale.","CEO Abbey Jenkins eligible for $287,500 transaction bonus; three other executives eligible for retention/transaction bonuses totaling up to $564,560."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-041748","json":"https://secwatch.observer/filing/0001213900-23-041748.json","markdown":"https://secwatch.observer/filing/0001213900-23-041748.md","text":"https://secwatch.observer/filing/0001213900-23-041748.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1600847/000121390023041748/0001213900-23-041748-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1600847/000121390023041748/ea179036-8k_gamida.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T18:16:08.214661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c331bb7011","claim":"Shai Lankry changed role as Chief Financial Officer at Gamida Cell Ltd..","evidence_excerpt":"On May 22, 2023, the Company also announced Shai Lankry would transition his role within the Company from Chief Financial Officer to Vice President, Finance beginning May 22, 2023 and will serve in such capacity until June 2, 2023, his final date of employment with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1600847/000121390023041748/0001213900-23-041748-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e8a6b074a8","claim":"Terry Coelho was appointed as Chief Financial Officer at Gamida Cell Ltd..","evidence_excerpt":"On May 22, 2023, Gamida Cell Ltd. (the “ Company ”) announced the appointment of Terry Coelho as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective May 22, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1600847/000121390023041748/0001213900-23-041748-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}